This interregional partnership (Strasbourg, Nancy and Lille) involves CNRS, INSERM, universities, university hospitals and cancer centers, as well as associations of patient’s parents.
This network between different teams provides a strong platform for multidisciplinary and multisectoral, fundamental, applied and medical research, which aims to improve knowledge on brain tumors and their resistance to radiotherapy.
This award gives the consortium the opportunity to become a driving force for more effective treatment of young patients with the highly aggressive tumors.
